Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹1 Cr
Revenue (TTM)
₹0 Cr
Net Profit (TTM)
₹0 Cr
ROE
0 %
ROCE
-0.5 %
P/E Ratio
--
P/B Ratio
--
Industry P/E
44.74
EV/EBITDA
--
Div. Yield
0 %
Debt to Equity
--
Book Value
₹--
EPS
₹-0
Face value
10
Shares outstanding
3,558,300
CFO
--
EBITDA
--
Net Profit
--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1992
Chairman
Arun Goyal
Managing Director
--
Headquarters
Indore, Madhya Pradesh
Website
Annual Reports
Since, TTM earnings of Dujohn Laboratories Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2010
|
0.00
|
0.00
|
|
2009
|
0.00
|
0.00
|
|
2010
|
0.00
|
0.00
|
|
2009
|
0.00
|
0.00
|
The 52-week high and low of Dujohn Laboratories Ltd are Rs -- and Rs -- as of 05-Apr-2026.
Dujohn Laboratories Ltd has a market capitalisation of ₹ 1 Cr as on 06-Jul-2001. As per SEBI classification, it is a company.
Before investing in Dujohn Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.